Alkylating anticancer agents and phagocytosis. II. Effects of alkylating agents on numerical distribution and histochemistry of reticuloendothelial cells.
D000135:Acid Phosphatase / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology; D001562:Benzimidazoles / Q000494:pharmacology*; D002244:Carbon; D046508:Culture Techniques; D003520:Cyclophosphamide / Q000494:pharmacology*; D004950:Esterases / Q000378:metabolism; D007728:Kupffer Cells / Q000187:drug effects; D008099:Liver / Q000166:cytology / Q000201:enzymology; D008264:Macrophages / Q000187:drug effects; D008297:Male; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000187:drug effects*; D009280:Naphthaleneacetic Acids; D009708:Nucleotidases / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects; D013154:Spleen / Q000166:cytology / Q000201:enzymology
D001562:Benzimidazoles; D009280:Naphthaleneacetic Acids; D002244:Carbon; D003520:Cyclophosphamide; D004950:Esterases; D009708:Nucleotidases; D000135:Acid Phosphatase; D000251:Adenosine Triphosphatases